Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging-Reference-Cited by-同舟云学术

Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging

Published:2023-12-29 Issue:1 Volume:14 Page:81
ISSN:2075-4418
Container-title:Diagnostics
language:en
Short-container-title:Diagnostics

Author:

Brittain Jane Maestri¹^ORCID,Hansen Michael Stormly²^ORCID,Carlsen Jonathan Frederik³⁴^ORCID,Brandt Andreas Hjelm³,Terslev Lene⁴⁵,Jensen Mads Radmer⁶,Lindberg Ulrich⁷,Larsson Henrik Bo Wiberg⁷,Heegaard Steffen²⁸,Døhn Uffe Møller⁵,Klefter Oliver Niels²⁴^ORCID,Wiencke Anne Katrine²⁴,Subhi Yousif²⁹¹⁰^ORCID,Hamann Steffen²⁴^ORCID,Haddock Bryan¹

Affiliation:

1. Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, DK-2100 Copenhagen, Denmark

2. Department of Ophthalmology, Rigshospitalet, DK-2600 Glostrup, Denmark

3. Department of Radiology, Rigshospitalet, DK-2100 Copenhagen, Denmark

4. Department of Clinical Medicine, University of Copenhagen, DK-2200 Copenhagen, Denmark

5. Department of Rheumatology and Spine Diseases, Rigshospitalet, DK-2600 Glostrup, Denmark

6. Department of Clinical Physiology and Nuclear Medicine, Bispebjerg Hospital, DK-2400 Copenhagen, Denmark

7. Functional Imaging Unit, Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, DK-2600 Glostrup, Denmark

8. Eye Pathology Section, Department of Pathology, Rigshospitalet, DK-2100 Copenhagen, Denmark

9. Department of Clinical Research, University of Southern Denmark, DK-5000 Odense, Denmark

10. Department of Ophthalmology, Zealand University Hospital, DK-4000 Roskilde, Denmark

Abstract

In order to support or refute the clinical suspicion of cranial giant cell arteritis (GCA), a supplemental imaging modality is often required. High-resolution black blood Magnetic Resonance Imaging (BB MRI) techniques with contrast enhancement can visualize artery wall inflammation in GCA. We compared findings on BB MRI without contrast enhancement with findings on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/low-dose computed tomography (2-[18F]FDG PET/CT) in ten patients suspected of having GCA and in five control subjects who had a 2-[18F]FDG PET/CT performed as a routine control for malignant melanoma. BB MRI was consistent with 2-[18F]FDG PET/CT in 10 out of 10 cases in the group with suspected GCA. In four out of five cases in the control group, the BB MRI was consistent with 2-[18F]FDG PET/CT. In this small population, BB MRI without contrast enhancement shows promising performance in the diagnosis of GCA, and might be an applicable imaging modality in patients.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Link

https://www.mdpi.com/2075-4418/14/1/81/pdf

Reference32 articles.

1. Medium- and Large-Vessel Vasculitis;Saadoun;Circulation,2021

2. A Meta-analysis of the Epidemiology of Giant Cell Arteritis across Time and Space;Li;Arthritis Res. Ther.,2021

3. Seasonal variation in biopsy-proven giant cell arteritis in Eastern Denmark from 1990–2018;Hansen;Acta Opthhalmol.,2021

4. Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis: A Systematic Review and Meta-analysis;Sandovivi;JAMA Intern. Med.,2020

5. Dejaco, C., Ramiro, S., Bond, M., Bosch, P., Ponte, C., Mackie, S.L., Bley, T.B., Blockmans, D., Brolin, S., and Bolek, E.C. (Ann. Rheum. Dis, 2023). EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update, Ann. Rheum. Dis, Epub ahead of print.